A comparative analysis of human and mouse islet G-protein coupled receptor expression S Amisten, P Atanes, R Hawkes, I Ruz-Maldonado, B Liu, F Parandeh, ... Scientific reports 7 (1), 46600, 2017 | 76 | 2017 |
Anti-diabetic action of all-trans retinoic acid and the orphan G protein coupled receptor GPRC5C in pancreatic β-cells S Amisten, IM Al-Amily, A Soni, R Hawkes, P Atanes, SJ Persaud, ... Endocrine Journal 64 (3), 325-338, 2017 | 39 | 2017 |
C3aR and C5aR1 act as key regulators of human and mouse β-cell function P Atanes, I Ruz-Maldonado, A Pingitore, R Hawkes, B Liu, M Zhao, ... Cellular and molecular life sciences 75, 715-726, 2018 | 38 | 2018 |
Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation P Atanes, T Ashik, SJ Persaud Pharmacology & Therapeutics 228, 107928, 2021 | 29 | 2021 |
LH‐21 and abnormal cannabidiol improve β‐cell function in isolated human and mouse islets through GPR55‐dependent and‐independent signalling I Ruz‐Maldonado, A Pingitore, B Liu, P Atanes, GC Huang, D Baker, ... Diabetes, Obesity and Metabolism 20 (4), 930-942, 2018 | 27 | 2018 |
Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles J Selent, M Marti-Solano, J Rodríguez, P Atanes, J Brea, M Castro, F Sanz, ... European Journal of Medicinal Chemistry 77, 91-95, 2014 | 25 | 2014 |
Defining G protein-coupled receptor peptide ligand expressomes and signalomes in human and mouse islets P Atanes, I Ruz-Maldonado, R Hawkes, B Liu, M Zhao, GC Huang, ... Cellular and Molecular Life Sciences 75, 3039-3050, 2018 | 22 | 2018 |
The cannabinoid ligands SR141716A and AM251 enhance human and mouse islet function via GPR55-independent signalling I Ruz-Maldonado, B Liu, P Atanes, A Pingitore, GC Huang, P Choudhary, ... Cellular and Molecular Life Sciences 77, 4709-4723, 2020 | 21 | 2020 |
The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes P Atanes, V Lee, GC Huang, SJ Persaud Metabolism 113, 154394, 2020 | 20 | 2020 |
Identifying signalling pathways regulated by GPRC5B in β-cells by CRISPR-cas9-mediated genome editing P Atanes, I Ruz-Maldonado, R Hawkes, B Liu, SJ Persaud, S Amisten Cellular Physiology and Biochemistry 45 (2), 656-666, 2018 | 19 | 2018 |
CXCL14 inhibits insulin secretion independently of CXCR4 or CXCR7 receptor activation or cAMP inhibition P Atanes, RG Hawkes, OE Olaniru, I Ruz-Maldonado, S Amisten, ... Cellular physiology and biochemistry: international journal of experimental …, 2019 | 14 | 2019 |
Assessing mouse islet function P Atanes, I Ruz-Maldonado, OE Olaniru, SJ Persaud Animal Models of Diabetes: Methods and Protocols, 241-268, 2020 | 11 | 2020 |
SNAP-tag-enabled super-resolution imaging reveals constitutive and agonist-dependent trafficking of GPR56 in pancreatic β-cells OE Olaniru, J Cheng, J Ast, A Arvaniti, P Atanes, GC Huang, AJF King, ... Molecular metabolism 53, 101285, 2021 | 9 | 2021 |
The arylpiperazine derivatives N‐(4‐cyanophenylmethyl)‐4‐(2‐diphenyl)‐1‐piperazinehexanamide and N‐benzyl‐4‐(2‐diphenyl)‐1‐piperazinehexanamide exert a long … P Atanes, E Lacivita, J Rodríguez, J Brea, J Burgueño, JM Vela, ... Pharmacology Research & Perspectives 1 (2), 2013 | 9 | 2013 |
In vitro profiling and functional assessments of the anti‐diabetic capacity of phenolic‐rich extracts of Bulbine natalensis and Bulbine frutescens SO Oyedemi, P Atanes, OA Aiyegoro, SO Amoo, SS Swain, SJ Persaud Diabetic Medicine 40 (2), e14770, 2023 | 8 | 2023 |
GPCR targets in type 2 diabetes P Atanes, SJ Persaud GPCRs, 367-391, 2020 | 8 | 2020 |
Quantification of changes in human islet G protein‐coupled receptor mRNA expression in obesity Z Lyu, M Zhao, P Atanes, SJ Persaud Diabetic Medicine 39 (12), e14974, 2022 | 5 | 2022 |
Direct Stimulatory Effects of the CB2 Ligand JTE 907 in Human and Mouse Islets I Ruz-Maldonado, P Atanes, GC Huang, B Liu, SJ Persaud Cells 10 (3), 700, 2021 | 2 | 2021 |
Alterations in mouse visceral adipose tissue mRNA expression of islet G‐protein‐coupled receptor ligands in obesity T Ashik, V Lee, P Atanes, SJ Persaud Diabetic Medicine 39 (12), e14978, 2022 | 1 | 2022 |
Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide D Cikes, P Atanes, SJF Cronin, A Hagelkrüys, GC Huang, SJ Persaud, ... Scientific Reports 12 (1), 9383, 2022 | 1 | 2022 |